At the 12 mg dose level, here is what clinical trials reported: Nausea: 43.2% of participants (versus 10.7% on placebo) Diarrhea: 33.1% of participants (versus 13.4% on placebo) Constipation: 25.0% of participants (versus 8.7% on placebo) Vomiting: 20.9% of participants These percentages tell an important story
Hold the medication under your tongue for at least 90 seconds without swallowing
And you have to point it out to the individual
The EC50 of GLP1 (7-36) is in the expected 2 digits pM range (25-60pM), while its metabolite shows a potency which is 4 logs lower and falls into the low M range
Every batch is independently evaluated for identity, HPLC purity, net peptide content, five heavy metals, bacterial endotoxin, and a rapid microbial screen, and every result is published on the batch COA
[4] [3] These complementary actions make GLP-1 essential for maintaining stable blood sugar levels throughout the day